Xellia Pharmaceuticals (US Finished Dosage Form Business and Assets) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Xellia Pharmaceuticals (US Finished Dosage Form Business and Assets) General Information

Description

Operator of Finished Dosage Form business based in Cleveland, Ohio. The business unit develops, manufactures, packs and distributes lyophilized vials and aseptically filled ready-to-use IV bag products.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Cleveland, OH
  • United States
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • Cleveland, OH
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Xellia Pharmaceuticals (US Finished Dosage Form Business and Assets) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Xellia Pharmaceuticals (US Finished Dosage Form Business and Assets)‘s full profile, request access.

Request a free trial

Xellia Pharmaceuticals (US Finished Dosage Form Business and Assets) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Xellia Pharmaceuticals (US Finished Dosage Form Business and Assets)‘s full profile, request access.

Request a free trial

Xellia Pharmaceuticals (US Finished Dosage Form Business and Assets) FAQs

  • Where is Xellia Pharmaceuticals (US Finished Dosage Form Business and Assets) headquartered?

    Xellia Pharmaceuticals (US Finished Dosage Form Business and Assets) is headquartered in Cleveland, OH.

  • What industry is Xellia Pharmaceuticals (US Finished Dosage Form Business and Assets) in?

    Xellia Pharmaceuticals (US Finished Dosage Form Business and Assets)’s primary industry is Pharmaceuticals.

  • Is Xellia Pharmaceuticals (US Finished Dosage Form Business and Assets) a private or public company?

    Xellia Pharmaceuticals (US Finished Dosage Form Business and Assets) is a Private company.

  • What is the current valuation of Xellia Pharmaceuticals (US Finished Dosage Form Business and Assets)?

    The current valuation of Xellia Pharmaceuticals (US Finished Dosage Form Business and Assets) is .

  • What is Xellia Pharmaceuticals (US Finished Dosage Form Business and Assets)’s current revenue?

    The current revenue for Xellia Pharmaceuticals (US Finished Dosage Form Business and Assets) is .

  • Who are Xellia Pharmaceuticals (US Finished Dosage Form Business and Assets)’s investors?

    Xellia Pharmaceuticals has invested in Xellia Pharmaceuticals (US Finished Dosage Form Business and Assets).

  • When was Xellia Pharmaceuticals (US Finished Dosage Form Business and Assets) acquired?

    Xellia Pharmaceuticals (US Finished Dosage Form Business and Assets) was acquired on 10-Sep-2024.

  • Who acquired Xellia Pharmaceuticals (US Finished Dosage Form Business and Assets)?

    Xellia Pharmaceuticals (US Finished Dosage Form Business and Assets) was acquired by Hikma Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process